Original Article

Transfusion Requirements in ESRD Patients Admitted with GI Hemorrhage Undergoing Inpatient Endoscopy

Authors: Conor McCartney, MD, Shrihari Santosh, PhD, Setu Patolia, MD, Sadashiv Santosh, MD

Abstract

Objectives: To date there are no studies evaluating the utilization of blood products in patients with end-stage renal disease (ESRD) with gastrointestinal (GI) hemorrhage. This study estimated transfusion needs and determined predictors available at the time of admission for patients with ESRD admitted to a university hospital with GI bleeding requiring inpatient endoscopy.

Methods: A retrospective chart review was performed on all patients with ESRD who underwent inpatient endoscopy for suspected GI bleeding between 2009 and 2015.

Results: Ninety-nine hospital admissions from 76 patients met the inclusion criteria. Patients received mean 2.9 ± 2.6 red blood cell (RBC) units. In the multivariate analysis, increased prothrombin time, low initial hemoglobin, admission to intensive care unit, congestive heart failure, white race (P = 0.08), and syncope (P = 0.09) were independent predictors of RBC transfusion. A total of 28% received fresh frozen plasma and 8% received platelets. Prolonged prothrombin time was the only independent predictor of fresh frozen plasma transfusion (P < 0.001). Platelet transfusion was predicted by thrombocytopenia at platelet counts <100,000/mm3 (P < 0.001) and white race. Coronary artery disease was associated with reduced platelet transfusion. Other baseline comorbidities, bleeding source, and active/recent hemorrhage on endoscopy did not predict transfusion. Desmopressin use was not associated with reduced RBC needs, even after adjusting for other covariates. Ninety-seven percent of patients survived to discharge.

Conclusions: Patients with ESRD admitted to the hospital with GI bleeding have high blood transfusion requirements, which are predicted by variables available at the time of admission. Rockall score and most other predictors of mortality did not predict transfusion.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Yang JY, Lee TC, Montez-Rath ME, et al. Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients. J Am Soc Nephrol 2012;23: 495-506.
 
2. Trivedi H, Yang J, Szabo A. Gastrointestinal bleeding in patients on long-term dialysis. J Nephrol 2015;28:235-243.
 
3. Sood P, Kumar G, Nanchal R, et al. Chronic kidney disease and end-stage renal disease predict higher risk of mortality in patients with primary upper gastrointestinal bleeding. Am J Nephrol 2012;35:216-224.
 
4. Halland M, Young M, Fitzgerald MN, et al. Characteristics and outcomes of upper gastrointestinal hemorrhage in a tertiary referral hospital. Dig Dis Sci 2010;55:3430-3435.
 
5. Hearnshaw SA, Logan RF, Palmer KR, et al. Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 2010;32:215-224.
 
6. Longstreth GF. Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1997;92:419-424.
 
7. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013;368:11-21.
 
8. Rockall TA, Logan RF, Devlin HB, et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996;38:316-321.
 
9. Imperiale TF, Dominitz JA, Provenzale DT, et al. Predicting poor outcome from acute upper gastrointestinal hemorrhage. Arch Intern Med 2007;167: 1291-1296.
 
10. Yang JY, Lee TC, Montez-Rath ME, et al. Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study. BMC Nephrol 2013;14:97.
 
11. Marmo R, Koch M, Cipolletta L, et al. Predictive factors of mortality from nonvariceal upper gastrointestinal hemorrhage: a multicenter study. Am J Gastroenterol 2008;103:1639-1648.
 
12. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet 2000;356: 1318-1321.
 
13. Yuan M, Lin Y. Model selection and estimation in regression with grouped variables. J R Stat Soc Series B Stat Methodol 2006;68:49-67.
 
14. Belloni A, Chernozhukov V. Least squares after model selection in high-dimensional sparse models. Bernoulli 2013;19:521-547.
 
15. Razzaghi A, Barkun AN. Platelet transfusion threshold in patients with upper gastrointestinal bleeding: a systematic review. J Clin Gastroenterol 2012;46: 482-486.
 
16. Weng SC, Shu KH, Tarng DC, et al. In-hospital mortality risk estimation in patients with acute nonvariceal upper gastrointestinal bleeding undergoing hemodialysis: a retrospective cohort study. Ren Fail 2013;35:243-248.
 
17. Furkert JD, Zeier M, Schwenger V. Gastrointestinal hemorrhage in hemodialysis patients. Z Gastroenterol 2008;46:1266-1269.
 
18. Jun M, James MT, Manns BJ, et al. The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study. BMJ 2015;350:h246.
 
19. Holden RM, Harman GJ, Wang M, et al. Major bleeding in hemodialysis patients. Clin J Am Soc Nephrol 2008;3:105-110.
 
20. Liang CC, Wang SM, Kuo HL, et al. Upper gastrointestinal bleeding in patients with CKD. Clin J Am Soc Nephrol 2014;9:1354-1359.
 
21. Wasse H, Gillen DL, Ball AM, et al. Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients. Kidney Int 2003;64: 1455-1461.
 
22. Hedges SJ, Dehoney SB, Hooper JS, et al. Evidence-based treatment recommendations for uremic bleeding. Nat Clin Pract Nephrol 2007;3: 138-153.
 
23. Couch P, Stumpf JL. Management of uremic bleeding. Clin Pharm 1990;9:673-681.
 
24. DeLoughery TG. Management of bleeding with uremia and liver disease. Curr Opin Hematol 1999;6:329-333.
 
25. Mannucci PM, Remuzzi G, Pusineri F, et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983;308:8-12.
 
26. Watson AJ, Keogh JA. Effect of 1-deamino-8-D-arginine vasopressin on the prolonged bleeding time in chronic renal failure. Nephron 1982;32:49-52.
 
27. Steiner RW, Coggins C, Carvalho AC. Bleeding time in uremia: a useful test to assess clinical bleeding. Am J Hematol 1979;7:107-117.